Your Commercial Payer Rates May Be Standing Still While Practice Costs Rise

Reimbursement & Payer Contracting

A medical practice can be busy, collections can still be moving, and yet the economics of the business can quietly get worse. One reason is easy to miss: the practice may be operating on commercial payer rates that have not meaningfully changed in years.

That is not a theoretical concern. An August 25, 2026 MGMA Stat poll of 203 applicable respondents found that only 29% said their practice's most recent commercial payer rate increase occurred within the prior year. Another 17% said it had been one to two years, while 50% said it had been three years or longer; 4% selected N/A.

At the same time, the cost side of the practice is not standing still. A separate MGMA Stat report said 84% of medical groups had higher year-to-date operating costs in 2026 than in the same period of 2025. U.S. Bureau of Labor Statistics data also show that total compensation costs for private-industry health care and social assistance rose 3.8% over the 12 months ending June 2026. That BLS series covers a broad health care sector, not physician offices alone, but it provides context for labor-cost pressure.

The important point for a physician owner is not that every older contract is automatically a bad contract. It is that a contract can keep renewing while the business underneath it changes. If the practice does not know when its major rates were last reviewed, it may be making staffing, scheduling and growth decisions using reimbursement assumptions that belong to a different cost structure.

When volume grows but the economics do not

Practice leaders naturally watch total revenue, visits and collections. Those are essential measures, but they can hide a unit-economics problem.

Imagine a practice that sees more patients this year than last year. Total revenue can rise simply because volume rose. But if the amount collected per common service is flat while wages, benefits, rent, supplies, technology and payer-related administrative work cost more, the practice may be working harder for a smaller margin on each encounter.

MGMA's June 30, 2026 Stat poll, reported July 2, captured that tension. Among 221 applicable respondents, 47% reported higher year-to-date revenue than in 2025, 36% reported lower revenue, 14% were about the same and 2% were unsure. MGMA also reported comments from groups with flat revenue describing higher visit volume combined with lower payment per CPT code; groups with stronger revenue frequently cited payer-contract renegotiation, payer mix and contractual rate escalators among the contributors.

For leadership, that changes the question. 'Are collections up?' is not enough. A better question is: 'What is happening to reimbursement per unit of work for the services that matter most to this practice?'

Why commercial rates can stay unchanged for years

Commercial contracts do not necessarily force a practice to make a fresh pricing decision every year. MGMA notes that many agreements renew automatically. If no one is responsible for tracking the renewal date, reviewing the fee schedule and deciding whether action is warranted, another contract year can begin under the same economics.

Smaller practices can be especially exposed because payer contracting competes with more immediate work: staffing, credentialing, denials, scheduling, payroll, compliance and day-to-day patient operations. A contract that is paying 'well enough' may receive little attention until financial pressure becomes visible somewhere else.

There is also a data problem. A practice may know that a payer is frustrating, but not know whether the contracted rates themselves are weak, whether only a subset of high-volume codes are weak, whether payments are falling short of contract terms, or whether administrative friction is consuming so much staff time that the relationship is less valuable than the headline rate suggests.

That distinction matters. Contract age is a warning signal, not a verdict. A three-year-old agreement with meaningful escalators and acceptable performance may be healthier than a newer contract with lower rates, frequent denials or heavy administrative requirements.

Contracted rate and realized reimbursement are not the same thing

A fee schedule tells you what the contract says should happen for covered services under defined circumstances. The practice's real financial outcome depends on more than the fee schedule alone.

Payer mix matters. Coding and documentation matter. Eligibility and benefit structure matter. Denials and underpayments matter. Patient responsibility can affect how much of the allowed amount is ultimately collected and how long collection takes. Administrative burden matters because staff time spent resolving payer-specific problems is a real operating cost even when it never appears as a line item on the fee schedule.

That is why a payer relationship should not be judged only by a single percentage of Medicare or by a few familiar CPT codes. Leadership needs enough visibility to connect the contract to what actually happens in the revenue cycle.

A practice does not need to turn the physician owner into a managed-care analyst. But someone should be able to explain whether the practice is being paid according to the contract, whether rates on its most important services have changed over time, and whether the payer's administrative burden is growing faster than its financial value.

What practice leadership should be able to answer

For each major commercial payer, leadership should be able to get clear answers to a small set of questions:

1. When was the agreement or fee schedule last meaningfully renegotiated or updated?

2. Which services and CPT codes generate most of the practice's revenue from that payer, and what are the current allowed amounts for those services?

3. How much of the practice's commercial volume and collections depend on that payer?

4. Are actual payments matching the contracted terms, or are underpayments, denials or recoupments creating a gap?

5. What administrative burden comes with the payer relationship, including prior authorization, claim follow-up, appeals, portal work and policy exceptions?

Those questions are not a negotiation script. They are a management control. If the answers are unavailable, the practice cannot reliably tell whether a commercial contract is supporting the business or simply renewing in the background.

Price transparency changed the information available, but not the work required

Commercial reimbursement used to be difficult to benchmark because practices generally knew their own rates but had limited visibility into what other providers were being paid. Federal Transparency in Coverage rules changed part of that information gap.

CMS states that, as of July 1, 2022, most group health plans and issuers of group or individual health insurance coverage are required to publicly disclose machine-readable files containing in-network rates for covered items and services, along with allowed amounts and historical billed charges for out-of-network providers. The requirement does not apply to every plan or coverage arrangement, and the files themselves are not a turnkey benchmark. Still, they create an additional source of market information for practices and their advisers.

In practice, the files are large and technically difficult to use. A December 30, 2025 MGMA Stat poll of 207 applicable respondents found that 18% were using Transparency in Coverage negotiated-rate data in payer negotiations; 46% said they were not and 36% were unsure. Respondents cited limited awareness, uncertainty about value, and the time, tools or skills needed to turn large public files into usable CPT-level comparisons. MGMA also noted data-quality and completeness limitations that can make raw comparisons misleading without cleaning and context.

So the existence of public rate data does not mean every small practice should build its own analytics operation. It does mean that 'we have no way to know anything about the market' is less true than it used to be. The practical question is whether the practice can obtain a credible comparison through internal analysis, a consultant, an association resource or another reliable method.

What should trigger a leadership review?

There is no universal number of months or years after which every commercial contract becomes unacceptable. Market leverage, specialty, geography, payer concentration, contract language and service mix all matter.

Several signals nevertheless deserve attention: leadership cannot say when a major payer was last renegotiated; high-volume services have stayed flat while operating costs rise; the practice is increasing volume without seeing comparable improvement in margin; payments repeatedly do not match expected contract terms; or a payer consumes disproportionate staff time through denials, authorizations, appeals or manual follow-up.

The first step is not automatically to threaten termination or demand a percentage increase. It is to understand the relationship well enough to know what problem, if any, needs to be solved.

That may lead to a rate discussion. It may lead to an underpayment audit, a contract-language review, a workflow change, a payer-mix decision or no action at all. The value of the review is that the decision becomes intentional rather than accidental.

The leadership takeaway

Commercial payer contracting is easy to treat as a periodic administrative project. For a small medical practice, it is more useful to think of it as part of revenue-cycle governance.

A practice can improve coding, reduce denials and accelerate A/R and still feel financial pressure if reimbursement for its core services has not kept pace with the cost of delivering them. Conversely, a rate increase is not a cure-all if the payer relationship creates heavy denials, underpayments or collection friction.

The goal is not to negotiate every contract every year. The goal is to know which contracts matter, how old their economics are, what the practice is actually realizing from them, and when the gap between reimbursement and operating reality has become large enough to deserve leadership attention.

Healthcode RCM can support that visibility from the revenue-cycle side by helping practices examine payer mix, payment performance, denials, underpayments and the operational data needed for a more informed payer review. Contract interpretation or negotiation strategy may also require contracting or legal expertise, depending on the issue.

If your practice cannot answer when its largest commercial payer agreements were last meaningfully reviewed, that is not proof that the rates are wrong. It is a sign that the question is worth asking.